* Single pivotal study established statistical evidence that pimavanserin 40 mg does not worsen parkinson’s disease status
The post BRIEF-FDA staff backs Acadia’s drug to treat psychosis associated with Parkinson’s disease appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Single pivotal study established statistical evidence that pimavanserin 40 mg does not worsen parkinson’s disease status
The post BRIEF-FDA staff backs Acadia’s drug to treat psychosis associated with Parkinson’s disease appeared first on NASDAQ.